| London Jobs |
| Manchester Jobs |
| Liverpool Jobs |
| Nottingham Jobs |
| Birmingham Jobs |
| Cambridge Jobs |
| Glasgow Jobs |
| Bristol Jobs |
| Wales Jobs |
| London Jobs |
| Manchester Jobs |
| Liverpool Jobs |
| Nottingham Jobs |
| Birmingham Jobs |
| Cambridge Jobs |
| Glasgow Jobs |
| Bristol Jobs |
| Wales Jobs |
| Oil & Gas Jobs |
| Banking Jobs |
| Construction Jobs |
| Top Management Jobs |
| IT - Software Jobs |
| Medical Healthcare Jobs |
| Purchase / Logistics Jobs |
| Sales |
| Ajax Jobs |
| Designing Jobs |
| ASP .NET Jobs |
| Java Jobs |
| MySQL Jobs |
| Sap hr Jobs |
| Software Testing Jobs |
| Html Jobs |
| Job Location | Cambridgeshire |
| Education | Not Mentioned |
| Salary | Salary negotiable |
| Industry | Not Mentioned |
| Functional Area | Not Mentioned |
| Job Type | Permanent, full-time |
Wren Therapeutics Limited is seeking to appoint a talented scientist for its rapidly growing research division. The appointee will assist in running a busy experimental laboratory and perform routine cell culture and in vitro cell-based assays that are associated with pre-clinical candidate selection and validation of new drugs.Client DetailsWren therapeutics, founded in 2016, is a spin-off company from the University of Cambridge (UK) and Lund University(Sweden).The company is based at the University of Cambridge, in the recently opened Chemistry of Health Centre, and is focused on drug discovery and development for protein misfolding diseases. Alzheimers and Parkinsons diseases are widely known examples of this group for medical disorders, but others include type -2 diabetes and many rare diseases amongst the more than 50 in total.Protein misfolding diseases are one of the most critical global healthcare challenges of the 21st century. However, current strategies- in particular those driven by traditional drug discovery and biological approaches- have proven, at least to date, to be ineffective,On January 22nd, 2019, Wren announced an 18 million Series A financing from an international syndicate led by The Baupost Group with participation from Life Force Capital and a number of private investors.DescriptionKey Responsibilities: